Canine idiopathic thrombocytopenic purpura

Journal of Veterinary Internal Medicine

Volumn 10, Issue 4, 1996, Pages 207-218

  Lewis, David C ^a   Meyers, Kenneth M ^a,b  

^a KANSAS STATE UNIVERSITY   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; VINCRISTINE;

ANIMAL; ANIMAL DISEASE; DOG; DOG DISEASE; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SEXUAL DEVELOPMENT; SPLENECTOMY; THROMBOCYTE; THROMBOCYTE TRANSFUSION;

ANIMALS; BLOOD PLATELETS; DOG DISEASES; DOGS; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; MALE; PLATELET TRANSFUSION; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SEX CHARACTERISTICS; SPLENECTOMY; VINCRISTINE;

EID: 0030185252     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.1996.tb02052.x     Document Type: Review

References (178)

1. Aster RH. The immunologic thrombocytopenias. In: Kunicki TJ, George JN, eds. Platelet Immunobiology. Philadelphia, PA: JB Lippincott; 1989:387-435.
2. Berchtold P, Harris JP, Tani P, et al. Autoantibodies to platelet glycoproteins in patients with disease-related immune thrombocytopenia. Br J Haematol 1989;73:365-368.
3. Helfand SC, Couto CG, Madewell BR. Immune-mediated thrombocytopenia associated with solid tumors in dogs. J Am Anim Hosp Assoc 1985;21:787-794.
4. Keller ET. Immune-mediated disease as a risk factor for canine lymphoma. Cancer 1992;70:2334-2337.
5. Lewis DC, Meyers KM, Callan MB, et al. Detection of platelet-bound and serum platelet-bindable antibodies in the diagnosis of canine ITP. J Am Vet Med Assoc 1995;206:47-52.
6. Axthelm MK, Krakowka S. Canine distemper virus-induced thrombocytopenia. Am J Vet Res 1987;48:1269-1275.
7. Kristensen AT, Klausner JS, Weiss DJ, et al. Detection of antiplatelet antibody with a platelet immunofluorescence assay. J Vet Intern Med 1994;8:36-39.
8. Schwartz KA, Slichter SJ, Harker LA. Immune-mediated platelet destruction and thrombocytopenia in patients with solid tumors. Br J Haematol 1982;51:17-24.
9. Chong BH. Drug-induced immune thrombocytopenia. Platelets 1991;2:173-181.
10. Handagama P, Feldman BF. Thrombocytopenia and drugs. Vet Clin N Am Small Anim Prac 1988;18:51-65.
11. van Leeuwen EF, van der Ven JTM, Engelfriet CP, et al. Specificity of autoantibodies in autoimmune thrombocytopenia. Blood 1982;59:23-26.
12. Lewis DC, Meyers KM. Studies of platelet-bound and serum platelet-bindable immunoglobulins in dogs with idiopathic thrombocytopenic purpura. Exp Hematol 1996 24:696-701.
13. Evans RS, Takahasi K, Duane RT, et al. Primary thrombocytopenic purpura and acquired hemolytic anemia. Evidence for a common etiology. Arch Intern Med 1951;87:48-65.
14. Grindem CB, Breitschwerdt EB, Corbett WT, et al. Epidemiologic survey of thrombocytopenia in dogs: A report on 987 cases. Vet Clin Pathol 1991;20:38-43.
15. Cockburn C, Troy GC. A retrospective study of 62 cases of thrombocytopenia in the dog. Southwest Vet 1986;37:133-141.
16. Jans HE, Armstrong PJ, Price GS. Therapy of immune-mediated thrombocytopenia. A retrospective study of 15 dogs. J Vet Intern Med 1990;4:4-7.
17. Dodds WJ. Animal model of human disease. Immune-mediated thrombocytopenia, autoimmune thrombocytopenia, idiopathic thrombocytopenic purpura. Am J Pathol 1977;86:486-491.
18. Shulman NR, Marder VJ, Weinrach RS. Similarities between known antiplatelet antibodies and the factors responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies. Ann N Y Acad Sci 1965;124:499-542.
19. Wilkins RJ, Hurvitz AL, Dodds WJ. Immunologically mediated thrombocytopenia in the dog. J Am Vet Med Assoc 1973;163: 277-282.
20. McMillan RS, Tani P, Mason D. The demonstration of antibody binding to platelet associated antigens in patients with immune thrombocytopenic purpura. Blood 1980;56:993-995.
21. Trent RJ, Clancy RL, Davis V, et al. Immune complexes in thrombocytopenic patients: Cause or effect? Br J Haematol 1980; 44:645-654.
22. Ercilla MG, Borche L, Vives J, et al. Circulating immune complexes in immune thrombocytopenic purpura. Br J Haematol 1982;52:679-682.
23. Sinha AA, Lopez T, McDevitt HO. Autoimmune diseases: the failure of self tolerance. Science 1990;248:1380-1387.
24. Rodey GE. Anti-idiotypic antibodies and regulation of immune responses. Transfusion 1992;32:361-376.
25. Quagliata F, Karpatkin S. Impaired lymphocyte transformation and capping in autoimmune thrombocytopenic purpura. Blood 1979;53:341-349.
26. Semple JW, Bruce S, Freedman J. Suppressed natural killer cell activity in patients with chronic autoimmune thrombocytopenic purpura. Am J Hematol 1991;37:258-262.
27. Semple J, Freedman J. Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia. Blood 1991;78:2619-2625.
28. Garcia-Suarez J, Prieto A, Reyes E, et al. The clinical outcome of autoimmune thrombocytopenic purpura patients is related to their T cell immunodeficiency. Br J Haematol 1993;84:464-470.
29. - natural killer cells subset. Blood 1993;82:1538-1545.
30. Karpatkin S, Fotino M, Winchester R. Hereditary autoimmune thrombocytopenic purpura: An immunologic and genetic study. Ann Intern Med 1981;94:781-782.
31. Helmerhorst FM, Heaton DC, Crossen PE, et al. Familial thrombocytopenia associated with platelet autoantibodies and chromosome breakage. Hum Genet 1984;65:252-256.
32. Hashemi S, Drouin J, Trudel E, et al. Characterization of novel platelet and endothelial target antigens in a family with genetic susceptibility to autoimmunity. Am J Hematol 1991;38:293-303.
33. Williams DA, Maggio-Price L. Canine idiopathic thrombocytopenic purpura: Clinical observation and long-term follow-up in 54 cases. J Am Vet Med Assoc 1984;185:660-663.
34. Dodds WJ. Immune-mediated diseases of the blood. Adv Vet Sci Comp Med 1983;27:163-196.
35. Day MJ, Pennale WJ. Immune-mediated disease in the old English sheepdog. Res Vet Sci 1992;53:87-92.
36. Steinberg AD, Gourley MF, Klinman DM, et al. Systemic lupus erythematosus. Ann Intern Med 1991;115:548-559.
37. Friedman D, Nettl F, Schrieber AD. Effect of estradiol and steroid analogue on the clearance of immunoglobulin G-coated erythrocytes. J Clin Invest 1985;75:162-167.
38. Feldman BF, Handagama P, Lubberink AA. Splenectomy as adjunctive therapy for immune-mediated thrombocytopenia and hemolytic anemia in the dog. J Am Vet Med Assoc 1985;187:617-619.
39. Jackson ML, Kruth SA. Immune-mediated hemolytic anemia and thrombocytopenia in the dog: A retrospective study of 55 cases diagnosed from 1969 through 1983 at the Western College of Veterinary Medicine. Can Vet J 1985;26:245-250.
40. Joshi BC, Jain NC. Detection of antiplatelet antibody in serum and on megakaryocytes of dogs with autoimmune thrombocytopenia. Am J Vet Res 1976;37:681-685.
41. Halliwell REW. Autoimmune disease in the dog. Adv Vet Sei Comp Med 1978;22:221-263.
42. Stein M, Keller SE, Schliefer SJ. Stress and immunomodulation: The role of depression and neuroendocrine function. J Immunol 1985;135:827s-833s.
43. Drake CG, Kotzin BL. Superantigens. Biology, immunology, and potential role in disease. J Clin Immunol 1992;12:149-162.
44. Kaplan C, Morinet F, Cartron J. Virus-induced autoimmune thrombocytopenia and neutropenia. Semin Hematol 1992;29:34-44.
45. Bettaieb A, Fromont P, Louache F, et al. Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura. Blood 1992;80:160-169.
46. Shulman NR, Jordan JV. Platelet Kinetics. In: Colman RW, Hirsh J, Marder VJ, et al, eds. Hemostasis and Thrombosis, Basic Principles and Clinical Practice. Philadelphia, PA: JB Lippincott; 1987:452-529.
47. Ballem PJ, Segal AM, Stratton JR, et al. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance. J Clin Invest 1987;80:33-40.
48. Joshi BC, Jain NC. Experimental immunologic thrombocytopenia in dogs: a study of thrombocytopenia and megakaryocytopoiesis. Res Vet Sci 1977;22:11-17.
49. Murtaugh RJ, Jacobs RM. Suspected immune-mediated megakaryocytic hypoplasia or aplasia in a dog. J Am Vet Med Assoc 1985;186:1313-1315.
50. Hoffman R. Acquired pure amegakaryocytic thrombocytopenic purpura. Semin Hematol 1991;28:303-312.
51. George JN. Platelet immunoglobulin G: Its significance for the evaluation of thrombocytopenia and for understanding the origin of a-granule proteins. Blood 1990;76:859-870.
52. Court WS, Bozeman JM, Soong SJ, et al. Platelet surface-bound IgG in patients with immune and non-immune thrombocytopenia. Blood 1987;69:278-283.
53. Tijhuis GJ, Klaasen RJL, Modderman PW, et al. Quantification of platelet-bound immunoglobulins of different class and subclass using radiolabelled monoclonal antibodies. Assay condition and clinical application. Br J Haematol 1991;77:97-105.
54. Lewis DC, McVey DS, Callan MB. Flow-cytometric detection of platelet-bound and serum platelet-bindable IgG in dogs with immune-mediated thrombocytopenia. J Vet Intern Med 1995;9:189 (abstr).
55. Kelton JG. Platelet and red cell clearance is determined by the interaction of the IgG and complement on cells and the activity of the reticuloendothelial system. Transfus Med Rev 1987;1:75-84.
56. 3 in thrombocytopenic states. Br J Haematol 1983;54: 353-363.
57. Kunicki TJ, Newman PJ. The molecular immunology of human platelet proteins. Blood 1992;80:1386-1404.
58. van Vliet HHDM, Kappers-Klunne MC, van der Hel JWB, et al. Antibodies against glycosphingolipids in sera of patients with idiopathic thrombocytopenic purpura. Blood 1992;77:2207-2213.
59. 2 mediated and a function of storage. Blood 1992;80:3164-3172.
60. 111indium-oxine labeled platelets in idiopathic thrombocytopenic purpura: A quantitative study. Am J Hematol 1982;12:167-177.
61. Saleh MN, Moore DL, Lee JY, et al. Monocyte-platelet interaction in immune and nonimmune thrombocytopenia. Blood 1989; 74:1328-1331.
62. Hymes KB, Schuck MP, Karpatkin S. Regulation of autoimmune anti-platelet antibody mediated adhesion of monocytes to platelet GPIIb/IIIa: Effect of armed monocytes and the mac-1 receptor. Blood 1990;75:1813-1819.
63. Unkeless JC, Scigliano E, Freedman VH. Structure and function of human and murine receptors for IgG. Ann Rev Immunol 1988;6:251-281.
64. Clarkson SB, Bussel JB, Kimberly RP, et al. Treatment of refractory immune thrombocytopenic purpura with an anti-Fcγ-receptor antibody. N Engl J Med 1986;314:1236-1239.
65. Fleer A, van Schaik MLJ, von dem Borne AEGKr, et al. Destruction of sensitized erythrocytes by human monocytes in vitro: Effects of cytochalasin B, hydrocortisone and colchicine. Scand J Immunol 1978;8:515-524.
66. Sims PJ. Interaction of human platelets with the complement system. In: Kunicki TJ, George JN, eds. Platelet Immunobiology. Philadelphia, PA: JB Lippincott; 1989:354-383.
67. Tsubakio T, Tani P, Curd JG, et al. Complement activation in vitro by antiplatelet antibodies in chronic immune thrombocytopenic purpura. Br J Haematol 1986;63:293-300.
68. Shebani OI, Jain NC. Mechanism of platelet destruction in immune-mediated thrombocytopenia: In vitro studies with canine platelets exposed to heterologous and isologous antiplatelet antibodies. Res Vet Sci 1989;47:288-293.
69. McMillan R, Longmire RL, Yelenosky R, et al. Quantitation of platelet-binding IgG produced in vitro by spleens from patients with idiopathic thrombocytopenic purpura. N Engl J Med 1974;291: 812-817.
70. Shulman NR, Jordan JV. Platelet immunology. In: Colman RW, Hirsh J, Marder VJ, et al, eds. Hemostasis and Thrombosis, Basic Principles and Clinical Practice. Philadelphia, PA: WB Saunders; 1987:452-529.
71. Chang CS, Li CY, Cha SS. Chronic idiopathic thrombocytopenic purpura. Splenic pathologic features and their clinical correlation. Arch Pathol Lab Med 1993;117:981-985.
72. Hassan NM, Neiman RS. The pathology of the spleen in steroid-treated immune thrombocytopenic purpura. Am J Clin Pathol 1985;84:433-438.
73. Bloom JC, Meunier LD, Thiem PA, et al. Use of danazol for treatment of corticosteroid-resistant immune-mediated thrombocytopenia in a dog. J Am Vet Med Assoc 289;194:76-77.
74. Harker LA, Slichter SJ. The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 1972;287:155-159.
75. Jy W, Horstman LL, Arce M, et al. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 1992;119:334-345.
76. Owens MR. The role of platelet microparticles in hemostasis. Transfus Med Rev 1994;8:37-44.
77. George JN, Shattil SJ. The clinical importance of acquired abnormalities of platelet function. N Engl J Med 1991;324:27-39.
78. Clancy R, Jenkins E, Firkin B. Qualitative platelet abnormalities in idiopathic thrombocytopenic purpura. N Engl J Med 1992; 286:622-626.
79. Kristensen AT, Weiss DJ, Klausner JS. Platelet dysfunction associated with canine immune-mediated thrombocytopenia (ITP). J Vet Intern Med 1994;8:323-327.
80. Kitchens CS. Amelioration of endothelial abnormalities by prednisone in experimental thrombocytopenia in the rabbit. J Clin Invest 1977;60:1129-1134.
81. Giltay JC, Brinkman HJM, Viekke A, et al. The platelet glycoprotein Ia/IIa associated Br-alloantigen system is expressed by cultured endothelial cells. Br J Haematol 1990;75:557-560.
82. Northern J, Tvedten HW. Diagnosis of microthrombocytosis and immune-mediated thrombocytopenia in dogs with thrombocytopenia: 68 cases (1987-1989). J Am Vet Med Assoc 1992;200:368-372.
83. Tvedten H, Grabski S, Frame L. Estimating platelets and leukocytes on canine blood smears. Vet Clin Pathol 1988;17:4-6.
84. Weiss DH. Uniform evaluation and semiquantitative reporting of hematologic data in veterinary laboratories. Vet Clin Pathol 1984; 13:27-31.
85. Garg SK, Amorosi EL, Karpatkin S. Use of the megathrombocyte as an index of megakaryocyte number. N Engl J Med 1971; 284:11-17.
86. Meyers KM. Pathobiology of animal platelets. Adv Vet Sci Comp Med 1985;30:131-165.
87. Weiss DJ. Antibody-mediated suppression of erythropoiesis in dogs with red blood cell aplasia. Am J Vet Res 1986;47:2646-2648.
88. Jain NC. Schalm's Veterinary Hematology. 4th ed. Philadelphia, PA: Lea & Febiger; 1986:466-486.
89. Harvey JW. Ehrlichia platys infection (infectious cyclic thrombocytopenia of dogs). In: Greene CE, ed. Infectious Diseases of the Dog and Cat. Philadelphia, PA: WB Saunders; 1990:415-418.
90. Waddle JR, Littman MP. A retrospective study of 27 cases of naturally occurring canine ehrlichiosis. J Am Anim Hosp Assoc 1988;24:615-620.
91. Zucker-Franklin D, Karpatkin S. Red cell and platelet fragmentation in idiopathic autoimmune thrombocytopenic purpura. N Engl J Med 1977;297:517-523.
92. Sullivan PS. Immune-mediated thrombocytopenia: Recent advances in diagnosis and treatment. Proceedings of the 12th ACVIM Forum, San Francisco, CA, 1994:149-151.
93. Jones EC, Boyko WJ. Diagnostic value of bone marrow examination in isolated thrombocytopenia. Am J Clin Pathol 1985;84: 665-667.
94. Sullivan PS, Manning K, McDonald TP. Association of mean platelet volume and bone marrow megakaryocytopoiesis in thrombocytopenic dogs: 60 cases (1984-1993). J Am Vet Med Assoc 1995; 206:332-334.
95. Jain NC, Kono CS. The platelet factor-3 test for detection of canine antiplatelet antibody. Vet Clin Pathol 1970;9:10-14.
96. George JN. The origin and significance of platelet IgG. In: Kunicki TJ, Georg JN, eds. Platelet Immunobiology. Philadelphia, PA: JB Lippincott; 1989:305-336.
97. McVey DS, Shuman WS. Detection of antiplatelet immunoglobulin in thrombocytopenic dogs. Vet Immunol Immunopath 1989; 22:101-111.
98. Campbell KL, Wright GJ, Greene CE. Application of the enzyme-linked immunosorbent assay for the detection of antiplatelet antibodies in dogs. Am J Vet Res 1984;45:2561-2564.
99. Thiem PA, Abbott DL, Moroff S, et al. Preliminary findings on the comparison of flow cytometric and solid-phase radioimmunoassay techniques for the detection of serum antiplatelet antibodies in dogs. Vet Clin Pathol 1991;20:18 (abstr).
100. Kristensen AT, Weiss DJ, Klausner JS, et al. Comparison of microscopic and flow cytometric detection of platelet antibody in dogs suspected of having immune-mediated thrombocytopenia. Am J Vet Res 1994;55:1111-1114.
101. Lewis DC, McVey DS, Shuman WS, et al. Development and characterization of a flow-cytometric assay for detection of platelet-bound immunoglobulin G in dogs. Am J Vet Res 1995;12:1555-1558.
102. Waner T, Harrus S, Weiss DJ, et al. Demonstration of serum antiplatelet antibodies in experimental acute canine ehrlichiosis. Vet Immunol Immunopathol 1995;48:177-182.
103. Ruiz P, Gomez F, King M, et al. In vivo glucocorticoid modulation of guinea pig splenic macrophage Fc gamma receptors. J Clin Invest 1991;88:149-157.
104. Karpatkin S. The spleen and thrombocytopenia. Clin Hematol 1983;12:591-604.
105. O'Keefe DA, Couto CG. Fine-needle aspiration of the spleen as an aid in the diagnosis of splenomegaly. J Vet Intern Med 1987; 1:102-109.
106. Barr SC, Ludders JW, Looney AL, et al. Platelet aggregation in dogs after sedation with acepromazine and atropine and during subsequent general anesthesia and surgery. Am J Vet Res 1992;53: 2067-2070.
107. Feldman BF, Madewell BR, O'Neill S. Disseminated intravascular coagulation: Antithrombin, plasminogen, and coagulation abnormalities in 41 dogs. J Am Vet Med Assoc 1981;179:151-154.
108. Slappendel RJ. Disseminated intravascular coagulation. Vet Clin N Am Small Anim Pract 1988;18:169-184.
109. Hertzke DM, Cowan LA, Schoning P, et al. Glomerular ultrastructural lesions of idiopathic cutaneous and renal glomerular vasculopathy of greyhounds. Vet Pathol 1995;32:451-459.
110. Holloway SA, Senior DF. Hemolytic-uremic syndrome in dogs. J Vet Intern Med 1993;7:220-227.
111. Lewis DC, Bruyette DS, Kellerman DL. Thrombocytopenia subsequent to anticoagulant rodenticide-induced hemorrhage in dogs. J Vet Intern Med 1995;9:188 (abstr).
112. O'Donnell MR, Slichter SJ, Weiden PL, et al. Platelet and fibrinogen kinetics in canine tumors. Cancer Res 1981;41:1379-1383.
113. Madewell BR, Feldman BF, O'Neill S. Coagulation abnormalities in dogs with neoplastic disease. Thromb Haemost 1980;44: 35-38.
114. Madewell BR. Hematological and bone marrow cytological abnormalities in 75 dogs with malignant lymphoma. J Am Anim Resp Assoc 1986;22:235-240.
115. Hammer AS, Couto CG, Swardson C, et al. Hemostatic abnormalities in dogs with hemangiosarcoma. J Vet Intern Med 1991;5:11-14.
116. Grindem CB, Breitschwerdt EB, Corbett WT, et al. Thrombocytopenia associated with neoplasia in dogs. J Vet Intern Med 1994;8:400-405.
117. Rishniw M, Lewis DC. Localized consumptive coagulopathy associated with cutaneous hemangiosarcoma in a dog. J Am Anim Hosp Assoc 1994;30:261-264.
118. Price AS, Page RL, Fischer BM, et al. Efficacy and toxicity of doxorubicin/cyclophosphamide maintenance therapy in dogs with multicentric lymphosarcoma. J Vet Intern Med 1991;5:259-262.
119. Scott DW, Walton Dk, Manning TO, et al. Canine lupus erythematosus. I. Systemic lupus erythematosus. J Am Anim Hosp Assoc 1983;19:461-479.
120. Bloom JC, Thiem PA, Sellers TS, et al. Cephalosporin-induced immune cytopenia in the dog: Demonstration of erythrocyte-, neutrophil-, and platelet-associated IgG following treatment with cefazedone. Am J Hematol 1988;28:71-78.
121. Bloom JB, Blackmer SA, Bugelski PJ, et al. Gold-induced immune thrombocytopenia in the dog. Vet Pathol 1985;22:492-499.
122. Patrick CH, Lazarchick J. The effect of bacteremia on automated platelet measurements in neonates. Am J Clin Pathol 1990; 93:391-394.
123. Dow SW, Curtis Cr, Jones RL, et al. Bacterial culture of blood from critically ill dogs and cats: 100 cases (1985-1987). J Am Vet Med Assoc 1989;195:113-117.
124. McAnulty JF, Rudd RG. Thrombocytopenia associated with vaccination of a dog with a modified-live paramyxovirus vaccine. J Am Vet Med Assoc 1985;186:1217-1219.
125. Straw B. Decrease in platelet count after vaccination with distemper-hepatitis (DM) vaccine. Vet Med Small Anim Clinician 1978;73:725-726.
126. Dumpulin-Lagrange M, Capelle C. Evaluation of automated platelet counters for the enumeration and sizing of platelets in the diagnosis and management of hemostatic problems. Semin Thromb Hemostas 1983;9:235-244.
127. Berkman N, Michaeli Y, Or R, et al. EDTA dependent pseudothrombocytopenia: A clinical study of 18 patients and review of the literature. Am J Hematol 1991;36:195-201.
128. Robinson WH, Lewis DC, Byrne BA. EDTA-dependent pseudothrombocytopenia in a horse. Equine Pract 1994;16:24-28.
129. Crystal MA, Cotter SM. Acute hemorrhage: A hematologic emergency in dogs. Comp Cont Educ Pract Vet 1992;14:60-67.
130. Greene CE, Scoggin J, Thomas JE, et al. Vincristine in the treatment of thrombocytopenia in five dogs. J Am Vet Med Assoc 1982;180:140-143.
131. Berchtold P, McMillan R. Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood 1989;74:2309-2317.
132. Carr JM, Kruskall MS, Kaye JA, et al. Efficacy of platelet transfusions in immune thrombocytopenia. Am J Med 1986;80: 1051-1054.
133. Branehog I, Weinfeld A. Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP) before and during treatment with corticosteroids. Scand J Haematol 1974;12: 69-79.
134. Freund LA, Berild D, Hainau B. Haemostatic effect of prednisolone in thrombocytopenia. Scand J Haematol 1983;31:485-487.
135. Maca RD, Fry GL, Hoak JC. The effects of glucocorticoids on cultured human endothelial cells. Br J Haematol 1978;38:501-509.
136. Blajchman MA, Senyl FA, Hirsh J, et al. Shortening of the bleeding time in rabbits by hydrocortisone caused by inhibition of prostacyclin generation by the vessel wall. J Clin Invest 1979;63: 1026-1035.
137. Fujisawa K, Tani P, Piro L, et al. The effect of therapy on platelet-associated and plasma autoantibody in chronic immune thrombocytopenic purpura. Blood 1993;81:2872-2877.
138. Gernsheimer T, Stratton J, Ballem PJ, et al. Mechanisms of response to treatment in autoimmune thrombocytopenic purpura. N Engl J Med 1989;320:974-980.
139. Boumpas DT, Chrousos GP, Wilder RL, et al. Glucocorticoid therapy for immune-mediated diseases: Basic and clinical correlates. Ann Intern Med 1993;119:1198-1208.
140. Plumb DC. Veterinary Drug Handbook, White Bear Lake, MN: Pharma Vet; 1995.
141. von dem Borne AEG, Vos JJE, Pegels JA, et al. High dose intravenous methylprednisolone or high-dose intravenous gamma-globulin for autoimmune thrombocytopenia. BMJ 1988;296:249-250.
142. Andersen JC. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. N Engl J Med 1994;330:1560-1564.
143. Cook AK, Bertoy EH, Gregory CR, et al. Effect of oral cyclosporine (CS) in dogs with refractory immune-mediated anemia (IMA) or thrombocytopenia (ITP). J Vet Intern Med 1994;8:170 (abstr).
144. Nandschumacher RE. Immunosuppressive agents. In: Gilman AG, Rall TW, Nies AS, et al, eds. The Pharmacologic Basis of Therapeutics. New York, NY: Pergamon Press; 1990:1264-1276.
145. Helfand SC, Jain NC, Paul M. Vincristine-loaded platelet therapy for idiopathic thrombocytopenia in a dog. J Am Vet Med Assoc 1984;185:224-226.
146. Ahn YS, Harrington WJ, Mylvaganam R, et al. Slow infusion of vinca alkaloids in the treatment of idiopathic thrombocytopenic purpura. Ann Intern Med 1984;100:192-196.
147. Harris RA, Penington DG. The effects of low-dose vincristine on megakaryocyte colony-forming cells and megakaryocyte ploidy. Br J Haematol 1984;57:37-48.
148. Ahn YS, Harrington WJ, Seelman RC, et al. Vincristine therapy of idiopathic and secondary thrombocytopenias. New Engl J Med 1974;291:376-380.
149. Mackin AJ, Allen DG, Johnstone IB. Effects of vincristine sulfate and prednisone on platelet numbers and function in clinically normal dogs. Am J Vet Res 1995;56:100-108.
150. White JA. Effects of colchicine and vinca alkaloids on human platelets. III. Influence on primary internal contraction and secondary aggregation. Am J Pathol 1969;54:467-473.
151. Ogilvie GC, Felsburg PJ, Harris CW. Short-term effect of cyclophosphamide and azathioprine on selected aspects of the canine blastogenic response. Vet Immunol Immunopathol 1988;18:119-127.
152. Reiner A, Gernsheimer T, Slichter SJ. Pulse cyclophosphamide therapy for refractory autoimmune thrombocytopenic purpura. Blood 1995;2:351-358.
153. Quiquandon I, Fenaus P, Caulier MT, et al. Re-evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: A report on 53 cases. Br J Haematol 1990;74:223-228.
154. Najean Y, Dufour V, Rain JD, et al. The site of platelet destruction in thrombocytopenic purpura as a predictive index of the efficacy of splenectomy. Br J Haematol 1991;79:271-276.
155. Julia A, Araguas C, Rossello J, et al. Lack of useful clinical predictors of response to splenectomy in patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol 1990;76:250-255.
156. Ambriz P, Munoz R, Quintanar E, et al. Accessory spleen compromising response to splenectomy for idiopathic thrombocytopenic purpura. Radiology 1985;155:793-796.
157. Barbieri RL, Ryan KJ. Danazol: Endocrine pharmacology and therapeutic applications. Am J Obstet Gynecol 1981;141:453-463.
158. Stadtmauer EA, Cassileth PA, Edelstein M, et al. Danazol treatment of myelodysplastic syndromes. Br J Haematol 1991;77: 502-508.
159. Ahn YS, Rocha R, Mylvaganam R, et al. Long-term danazol therapy in autoimmune thrombocytopenia, unmaintained remission and age-dependent response in women. Ann Intern Med 1989;111: 723-729.
160. McVeny BA, Avger M, Bellingham AJ. The use of danazol in the management of chronic immune thrombocytopenic purpura. Br J Hematol 1985;61:145-148.
161. Mazzucconi MA, Francesconi M, Falcisne E, et al. Danazol therapy in refractory chronic immune thrombocytopenic purpura. Acta Haematol 1987;77:45-47.
162. Roseler BJ, Mason KV. Use of danazol and corticosteroids for the treatment of immune-mediated thrombocytopaenia in a dog. Aust Vet Pract 1994;24:126-130.
163. White JV. Cyclosporine: Prototype of a T-cell selective immunosuppressant. J Am Vet Med Assoc 1986;189:566-570.
164. Kelsey PR, Schofield KP, Geary CA. Refractory idiopathic thrombocytopenic purpura treated with cyclosporine. Br J Haematol 1985;60:179-203.
165. Slichter SJ, Deeg HJ, Kennedy MS. Prevention of platelet alloimmunization in dogs with systemic cyclosporine and by UV-irradiation or cyclosporine-loading of platelets. Blood 1987;69:414-418.
166. Rosenkrantz WS, Griffin CE, Barr RJ. Clinical evaluation of cyclosporine in animal models with cutaneous immune-mediated disease and epitheliotropic lymphoma. J Am Anim Hosp Assoc 1988;25:337-384.
167. Blanchette VS, Kirby MA, Turner C. Role of intravenous immunoglobulin G in autoimmune hematologic disorders. Semin Hematol 1992;29:72-82.
168. Berchtold P, Dale GL, Tani P, et al. Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIa by anti-idiotypic antibodies in intravenous gammaglobulin. Blood 1989;74:2414-2417.
169. Bussel JB, Pham LC. Intravenous treatment with gamma-globulin in adults with immune thrombocytopenic purpura: review of the literature. Vox Sang 1987;52:206-211.
170. Scott-Moncrieff JC, Regan WJ, Glickman LT, et al. Treatment of nonregenerative anemia with human γ-globulin in dogs. 1995;206:1895-1900.
171. Blanchette VS, Hogan VA, McCombie NE, et al. Intensive plasma exchange therapy in ten patients with idiopathic thrombocytopenic purpura. Transfusion 1984;24:388-394.
172. Jones FR, Balint JP, Snyder HW. Selective extracorporeal removal of immunoglobulin G and immune complexes: a review. Plasma Ther Transfus Technol 1986;7:333-349.
173. Matus RE, Schrader LA, Leifer CE, et al. Plasmapheresis as adjuvant therapy for autoimmune hemolytic anemia. J Am Vet Med Assoc 1985;186:691-693.
174. Matus RE, Gordon BR, Leifer CE, et al. Plasmapheresis in five dogs with systemic immune-mediated disease. J Am Vet Med Assoc 1985;187:595-599.
175. Hernandez F, Linares M, Colomina P, et al. Dapsone ofr refractory chronic idiopathic thrombocytopenic purpura. Br J Haematol 1995;90:473-475.
176. Kumakura S, Ishikura H, Endo J, et al. A favourable effect of long-term α-interferon therapy in refractory idiopathic thrombocytopenic purpura. Br J Haematol 1993;85:805-807.
177. Calverley DC, Jones GW, Kelton JG. Splenic irradiation for corticosteroid-resistant immune thrombocytopenia. Ann Intern Med 1992;116:977-981.
178. Karpatkin S, Garg SK, Siskind GW. Autoimmune thrombocytopenic purpura and the compensated thrombocytopenic state. Am J Med 1971;51:1-4.